Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Reporting of adverse drug reactions in randomised controlled trials – a systematic survey

6 references·16 citing·52 second hop

FromToDepth

this work references cited by second hop

References

2001The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials5,372 cited
2001The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials2,754 cited
1996Better reporting of randomised controlled trials: the CONSORT statement610 cited
2001Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas.564 cited
1994A Proposal for Structured Reporting of Randomized Controlled Trials307 cited
1999Reporting of Adverse Effects in Clinical Trials Should Be Improved167 cited

Cited by

2011A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research347 cited
2013Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension111 cited
2009The Value of “Traditional” Reviews in the Era of Systematic Reviewing103 cited
2018Rapid reviews may produce different results to systematic reviews: a meta-epidemiological study95 cited
2004Safety Reporting in Randomized Trials of Mental Health Interventions84 cited
2004Availability of large-scale evidence on specific harms from systematic reviews of randomized trials79 cited
2019Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota76 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2005Challenges in Systematic Reviews of Therapeutic Devices and Procedures70 cited

2004Assessing harmful effects in systematic Reviews69 cited

2008Reporting of adverse events in systematic reviews can be improved: survey results64 cited

2004Determining the reporting quality of RCTs in clinical pharmacology56 cited

2005Selective exposure reporting and Medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives54 cited

2005Reporting of Harm in Randomized, Controlled Trials of Nonpharmacologic Treatment for Rheumatic Disease49 cited

2011Comprehensive evaluations of the adverse effects of drugs: importance of appropriate study selection and data sources49 cited

2012The Reporting of Harms in Randomized Controlled Trials of Hypertension Using the CONSORT Criteria for Harm Reporting35 cited

2006Methodological shortcomings predicted lower harm estimates in one of two sets of studies of clinical interventions30 cited